5 Common Myths About Regenerative Medicine, Corrected

Regenerative medicine attracts both overblown promises and blanket dismissal. The reality sits in between. Here are five common claims and what the evidence supports.

Myth 1: "It's a cure that regrows your joint."

Reality: No currently available injection has been shown to regrow a worn-out joint. Research suggests that regenerative therapies may influence inflammation and the joint environment, and some studies report improvements in pain and function. The size and durability of the benefit varies, and results are not guaranteed.

Myth 2: "It's all unproven quackery."

Reality: Some regenerative approaches have a real research base. PRP, for example, has been studied in many clinical trials for knee osteoarthritis and tendon problems, with mixed results, and the American College of Rheumatology's 2026 osteoarthritis guideline strongly recommends against PRP for knee and hip osteoarthritis. The honest position is that evidence differs by therapy and condition, and for many cell-based and exosome therapies it is still early.

Myth 3: "If it's offered, the FDA must have approved it."

Reality: The FDA has not approved stem cell or exosome products for treating arthritis or most orthopedic conditions. Many such products are offered as investigational care without FDA approval. This is why informed consent matters: you should be told what is approved, what isn't, and what is known. See the FDA's consumer guidance.

Myth 4: "It's only for elite athletes."

Reality: The people who ask about regenerative care include weekend athletes, active retirees, and people whose joint pain interferes with work or family life. Candidacy is determined by clinical factors such as the joint involved, imaging, health history, and prior treatments, not by athletic status. And not everyone is a candidate.

Myth 5: "It's a one-and-done fix."

Reality: Even when people respond well, there's no guarantee of permanent results. Outcomes depend on the condition, the person, and supporting steps like exercise, weight management, and rehabilitation. Some people need repeat treatment, and some don't respond at all.

The Takeaway

Treat regenerative medicine as a developing field: promising in places, unproven in others. Choose a provider who is candid about that, puts a physician-supervised process behind every recommendation, and is willing to tell you "this isn't right for you."

Questions?

Take the 2-minute consult quiz or contact the team to talk with a licensed clinician. For independent reading, visit the ISSCR's patient resources.